课题基金 / 基金详情

项目摘要

项目成果

Patrick J Loll的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a proposal for a core facility to support a Program Project application. The main roles of this core (Core B) are to express and purify the protein targets for which anesthetic binding will be studied, and to provide structural support to the program. Aims 1 and 2 of this core proposal focus on the production and purification of eukaryotic potassium channels; these proteins include both anesthetic-sensitive and - insensitive channels (with the latter acting as negative controls, for example for photolabeling experiments). Target proteins include the voltage-gated potassium channels Shaw2 and Kvl.2. Aim 3 focuses on the production and purification of prokaryotic homologs of eukaryotic anesthetic targets, including the sodium channel NaChBac. All of these proteins will be expressed in heterologous systems and supplied to our colleagues, either in purified, detergent-solubilized form or as crude membrane fractions. Structural support will be supplied to the program in the form of crystallographic expertise; this expertise will be devoted to exploring crystallization conditions for the membrane proteins being studied as anesthetic targets, so as to enable future high-resolution analysis of anesthetic binding. We will also crystallize and determine structures for anesthetics bound to model proteins such as apoferritin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10304192
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10520037
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10062476
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Novel anti-HIV compounds targeting the HIV-1 matrix protein
  • 批准号:
    10196947
  • 项目类别:
  • 资助金额:
    $55.51万
  • 财政年份:
    2018
  • 负责人:
    Patrick J Loll
  • 依托单位:
海外基金